Ying Luo
Founder at GNI GROUP LTD.
Net worth: 23 M $ as of 30/04/2024
Ying Luo active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GNI GROUP LTD. | Director/Board Member | 01/06/2005 | - |
| Chief Executive Officer | 01/10/2007 | - | |
| Founder | 01/06/2005 | - | |
| President | 01/08/2008 | - | |
| Chief Operating Officer | 01/06/2005 | 01/08/2008 | |
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Chairman | 01/09/2011 | - |
| Director/Board Member | 01/07/2011 | 01/09/2011 | |
Shanghai GEP Pharmaceuticals, Inc.
 Shanghai GEP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shanghai GEP Pharmaceuticals, Inc. is a private company that manufactures pharmaceutical products. The company is based in Shanghai, China. | Chairman | 01/11/2017 | - |
| Cullgen Shanghai, Inc. | Chairman | 01/06/2018 | - |
Beijing Continent Pharmaceutical Co., Ltd.
 Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | Chairman | 01/09/2011 | - |
Cullgen, Inc.
 Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Cullgen, Inc. operates as a biopharmaceutical company. It develops chemical entities for the treatment of diseases lacking effective therapeutic approaches. The company was founded in 2018 and is headquartered in San Diego, CA. | Chief Executive Officer | 01/01/2018 | - |
| Chairman | 01/01/2018 | - | |
| Founder | 01/01/2018 | - | |
| President | 01/01/2018 | - | |
Shanghai Genomics, Inc.
 Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Founder | 01/05/2001 | - |
| Chairman | 01/04/2009 | - | |
| Chief Executive Officer | 01/04/2009 | 01/01/2021 | |
GNI USA, Inc.
 GNI USA, Inc. BiotechnologyHealth Technology GNI USA, Inc. engages in therapeutic pharmaceutical products development and production. The company was founded in 2001 and is headquartered in San Jose, CA. | Director/Board Member | 01/01/2015 | - |
| President | 01/01/2015 | - | |
GNI Hong Kong Ltd.
 GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services GNI Hong Kong Ltd. engages in property management. The company was founded on July 31, 2013 and is headquartered in Hong Kong. | Chief Executive Officer | 01/07/2013 | - |
| Chairman | 01/07/2013 | - | |
| President | - | - | |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ | ░░░░░░░░░░ | - |
Career history of Ying Luo
Former positions of Ying Luo
| Companies | Position | Start | End |
|---|---|---|---|
| ░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Ying Luo
| University of Connecticut Health Center | Doctorate Degree |
| Peking Union Medical College | Undergraduate Degree |
Statistics
International
| China | 10 |
| United States | 6 |
| Japan | 2 |
Operational
| Chairman | 10 |
| Chief Executive Officer | 5 |
| Director/Board Member | 4 |
Sectoral
| Health Technology | 10 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GNI GROUP LTD. | Health Technology |
| Private companies | 12 |
|---|---|
Shanghai Genomics, Inc.
Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Health Technology |
| Chinese National Genome Center | |
| GNI-EPS Pharmaceuticals, inc. | |
GNI Hong Kong Ltd.
GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services GNI Hong Kong Ltd. engages in property management. The company was founded on July 31, 2013 and is headquartered in Hong Kong. | Commercial Services |
GNI USA, Inc.
GNI USA, Inc. BiotechnologyHealth Technology GNI USA, Inc. engages in therapeutic pharmaceutical products development and production. The company was founded in 2001 and is headquartered in San Jose, CA. | Health Technology |
Berkeley Advanced Biomaterials, Inc.
 Berkeley Advanced Biomaterials, Inc. Pharmaceuticals: MajorHealth Technology Berkeley Advanced Biomaterials, Inc. manufactures and distributes calcium-based products. Its products include HAP/TCP, nanocrystals, powder, granules and blocks. The company was incorporated by François Génin in October 1996 and is headquartered in Berkeley, CA. | Health Technology |
Cullgen, Inc.
Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Cullgen, Inc. operates as a biopharmaceutical company. It develops chemical entities for the treatment of diseases lacking effective therapeutic approaches. The company was founded in 2018 and is headquartered in San Diego, CA. | Health Technology |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Health Technology |
Beijing Continent Pharmaceutical Co., Ltd.
Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | Health Technology |
| Cullgen Shanghai, Inc. | |
Shanghai GEP Pharmaceuticals, Inc.
Shanghai GEP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shanghai GEP Pharmaceuticals, Inc. is a private company that manufactures pharmaceutical products. The company is based in Shanghai, China. | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Ying Luo
- Experience